I believe you're correct about running additional
Post# of 15624
To me, their arrangement is far superior to having their products partnered with big Pharma's who'd pick up trial costs, and would do all else, but would make the lion's share of the earnings while paying OWCP for certain milestones that are achieved, as well as royalties on sales.
I believe that OWCP has positioned itself to potentially earn billions annually in the not that distant future while they'll be spending a few hundred millions on clinical trials and new product development.
Gary